-
Recent Posts
- Dementia and Elderly Care: the Latest Evidence Newsletter, Volume 3 Issue 7, May 2013
- Dementia Awareness Week: Thinking Ahead (UKMi)
- Reducing Health Inequalities: Health Professionals’ Roles (UCL Institute of Health Equity)
- Dying Well at Home: Integrated Working (SCIE)
- Documentation for the National Dementia Prevalence Calculator (NHS England / Dementia Partnerships)
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
Categories
- Antipsychotics
- Assistive Technology
- Charitable Bodies
- Commissioning
- Delirium
- Depression
- Enhancing the Healing Environment
- Falls
- Falls Prevention
- Guidelines
- Hip Fractures
- Housing
- Hypertension
- In the News
- Integrated Care
- International
- Local Interest
- Mental Health
- Models of Dementia Care
- National
- ADASS
- All-Party Parliamentary Group (APPG) on Dementia
- BSI
- CQC: Care Quality Commission
- Department of Health
- Housing LIN
- MAGDR
- Mental Health Foundation
- Mental Health Network (NHS Confederation)
- MHP Health Mandate
- National Audit Office
- National Voices
- NEoLCIN
- NEoLCP
- NHS
- NHS Alliance
- NHS Confederation
- NHS Evidence
- NICE Guidelines
- NIHR
- NIHRSDO
- Patients Association
- RCN
- Royal College of Physicians
- Royal College of Psychiatrists
- SCIE
- Scotland
- UK
- UK NSC
- Non-Pharmacological Treatments
- Nutrition
- Pain
- Parkinson's Disease
- Patient Care Pathway
- Person-Centred Care
- Personalisation
- Pharmacological Treatments
- Proposed for Next Newsletter
- Quick Insights
- Standards
- Statistics
- Stroke
- Systematic Reviews
- Telecare
- Telehealth
- Universal Interest
Category Archives: Pharmacological Treatments
Dementia Awareness Week: Thinking Ahead (UKMi)
Posted on May 24, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary This edition of Thinking Ahead, from UK Medicines Information (UKMi), has been written for Dementia Awareness Week May 19th – 25th 2013. Full Text Link (MS Word format). Reference Hall, J. (2013). Thinking Ahead: Worrying changes nothing. Talking changes everything. … Continue reading →
Posted in Alzheimer's Society, Antipsychotics, Charitable Bodies, Depression, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), Management of Condition, Mental Health, Models of Dementia Care, National, Patient Information, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK, Universal Interest
|
Tagged Alzheimer's Disease: Medicines, Dementia Awareness Week 2013, Dementia Awareness Week: Thinking Ahead, Depression in Dementia, Management of Medicines, Medicines Management, MHRA Drug Safety Updates, NICE Pathways, NICE Technology Appraisal Guidance: TA217, Saga Homecare: Dementia Awareness Week™, Supporting People to Live Well with Dementia: QS30 (NICE), UK Medicines Information (UKMi), UKMi
|
Leave a comment
EU ALCOVE Project: Latest Reports (ALCOVE Official Website / University of Worcester’s Association for Dementia Studies)
Posted on May 19, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
[A version of this collection features in Dementia and Elderly Care: the Latest Evidence Newsletter (RWNHST), Volume 3 Issue 7, May 2013]. Summary The European Joint Action on Dementia, ALCOVE, (¨ALzheimer’s COoperative Valuation in Europe¨ is into an “information dissemination” … Continue reading →
Posted in Antipsychotics, Department of Health, Diagnosis, For Doctors (mostly), For Researchers (mostly), Integrated Care, International, Management of Condition, Models of Dementia Care, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Standards, Systematic Reviews, UK
|
Tagged ALCOVE Dissemination: Europe (ALCOVE), ALCOVE Evaluation: Europe (ALCOVE), ALCOVE Official Website, ALCOVE Project, ALCOVE Recommendations, ALCOVE Synthesis Report: Europe (ALCOVE), ALCOVE Toolbox for Antipsychotics Limitation in Dementia, ALCOVE: ALzheimer's COoperative Valuation in Europe, ALzheimer Cooperative Valuation in Europe Group, ALzheimer's COoperative Valuation in Europe: ALCOVE, Alzheimer’s Early Screening, Antipsychotics Limitation in Dementia, Archives of Public Health, Assessment and Diagnosis, Assistance Publique-Hopitaux de Paris, Association for Dementia Studies, Athens Association of AD and Related Disorders (AAADRD), Autonomy, Autonomy and Choice, Barriers to the Diagnosis and Management of Patients with Dementia in Primary Care, Behavioral and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD Patient Pathway: Europe (ALCOVE), BPSD Support: Europe (ALCOVE), BPSD Toolkit: Europe (ALCOVE), BPSD: Behavioral and Psychological Symptoms of Dementia, BPSD: Europe (ALCOVE), Burden on Caregivers, Caregiver Support, Caregiving (Carers), Carer Support, Carers, Cognitive Screening, Cross-European ALCOVE Dementia Project, Dementia Data Sources in Europe, Dementia Diagnosis, Diagnosis, Diagnosis of Alzheimer's Disease, Dignity, Dignity in Dementia, Dr Bernie Coope: Lead Consultant for Older Adult Services with Worcestershire Mental Health Trust, Dr Karim Saad, Dr Karim Saad: Department of Health Clinical Adviser on the ALCOVE Project, Dr. Angela Giusti, Dr. Armelle Leperre Desplanques: ALCOVE Coordinator, Dr. Bénédicte Gombault, Dr. Catherine Helmer, Early Detection of Alzheimer’s Disease, Early Diagnosis, Early Diagnosis of Alzheimer's Disease, Early Screening, Elderly Human Rights, Epidemiological Data on Dementia: Europe (ALCOVE), Epidemiology, Epidemiology and Statistics, Espace Ethique (EEAPHP), EU ALCOVE Project, EU ALCOVE Project: Latest Reports, EuroCoDe: European Collaboration on Dementia, European Collaboration on Dementia: EuroCoDe, European Commission, European Commission's Public Health Programme, European Healthcare Policies on Dementia, European Joint Action on Dementia: ALCOVE, European Union (EU), Family Caregivers, Fondation Roi Baudouin (KBF), Fundación Vasca de Innovación e Investigación Sanitarias (BIOEF), GPs, HAS (French National Authority for Health), Haute Autorité de Santé (HAS), Healthcare Policies in Europe, Institut National de la Santé et la Recherché Médicale (INSERM), Institute of Neuroimmunology: Slovak Academy of Sciences (NIU SAV), Instituto Superiori di Sanità (ISS), Jerry Bird: Department of Health Project Manager on the Dementia Strategy, Joint Action Between EU Member States: ALCOVE, Karolinska Institute (KI), Karolinska Institutet (Stockholm), Karolinska Institutet Alzheimer Disease Research Centre, Lithuanian University of Health Sciences (LUHS), Memory Clinics, Ministero della Salute (MINSAL UNIBS), Ministero della Salute (MINSAL), Peter Ashley: Alzheimer’s Society Ambassador, Prevalence of Dementia, Prof. Michal Novak, Prof. Pierre Krolak-Salmon, Prof. Tomas López-Peña Ordoñez, Professor Alistair Burns, Professor Dawn Brooker, Psychological Symptoms of Dementia (BPSD), Public Health, Public Health Research: ALCOVE, Riga Centre of Psychiatry and Addiction Disorders (RPNC), Rights, Rights Autonomy and Dignity: Europe (ALCOVE), Screening, Social Epidemiology, Support for Carers, Supporting Caregivers, Terveyden ja Hyvinvoinnin Laitos (THL), Timely Diagnosis, Timely Diagnosis of Dementia: ALCOVE / University of Worcester, Toolbox for Antipsychotics Limitation in Dementia, Toolbox for Antipsychotics Limitation in Dementia: Europe (ALCOVE), University of Worcester, University of Worcester: Association for Dementia Studies, Unpaid Caregivers (Carers), Worcester University
|
Leave a comment
PEARL Specialised Dementia Service Confirms Reduced Requirement for Antipsychotic Medication (Four Seasons Health Care)
Posted on May 16, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary This report covers the progress of Four Seasons Health Care in halving use of antipsychotic medication for adults with dementia through their specialist PEARL (Positively Enriching And enhancing Residents’ Lives) care programme. Many positive outcomes are reported. Full Text … Continue reading →
Posted in Antipsychotics, Community Care, Depression, Falls, Falls Prevention, For Carers (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), Management of Condition, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Quick Insights, Standards, UK, Universal Interest
|
Tagged Alternatives to Antipsychotic Medication, Animal Assisted Therapy, Antipsychotic Drugs, Antipsychotic Prescribing in Nursing Homes in the United States, Antipsychotics, Antipsychotics in Elderly People with Dementia, Atypical Antipsychotics, Behavioral and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Care Homes, Dementia Care Mapping, Dementia Care Mapping (DCM), Doll Therapy, Four Seasons Health Care, Music Therapy, Music Therapy for BPSD, PEARL (Positively Enriching And enhancing Residents' Lives) Care Programme, PEARL Specialised Dementia Service, Pets, Pets as Companions for People with Dementia, Photographs and Memory Boxes, Positively Enriching and Enhancing Residents' Lives: PEARL Care Programme, Professor Dawn Brooker, Reduced Requirement for Antipsychotic Medication, Reducing Antipsychotic Medication in Care Homes, Residential Care Homes, Rummage and Memory Boxes, Supportive Care, Supportive Design for People with Dementia, Supportive Environments, University of Worcester, University of Worcester; Institute of Health and Society, Worcester University
|
Leave a comment
Medicines Optimisation: Helping Patients for Medication Best Usage (Royal Pharmaceutical Society)
Posted on May 4, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary The Royal Pharmaceutical Society has release guidance which helps health and care professionals to assist patients with their medicines to improve outcomes and avoid waste. The “Medicines Optimisation: Helping Patients Make the Most of Medicines” document offers four guiding … Continue reading →
Posted in For Carers (mostly), For Nurses and Therapists (mostly), For Social Workers (mostly), Management of Condition, National, Person-Centred Care, Pharmacological Treatments, Practical Advice, Proposed for Next Newsletter, Quick Insights, Standards, UK, Universal Interest
|
Tagged Avoidable Harm, Avoidable Ill-Health, Best Practice, Checking Medication, Four Principles of Medicines Optimisation, Medication, Medication Errors, Medications: Best Usage, Medicines Optimisation, Patient Experience, Royal Pharmaceutical Society
|
Leave a comment
Resources to Reduce Inappropriate Use of Antipsychotics in Dementia (UKMi / East & South East England Specialist Pharmacy Services)
Posted on May 3, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary This document assembles a collection of resources to support primary and secondary care pharmacists in reducing the inappropriate use of antipsychotics for patients showing Behavioural and Psychological Symptoms of Dementia (BPSD). The resources are based on the “Medicines Use … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Person-Centred Care, Pharmacological Treatments, Practical Advice, Proposed for Next Newsletter, Quick Insights, Standards, UK, Universal Interest
|
Tagged Alternatives to Antipsychotic Drugs, Alternatives to Antipsychotic Medication, Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Antipsychotics-Related Mortality Risks, Atypical Antipsychotics, Audit of Antipsychotic Prescribing in Dementia Patients, Behavioral and Psychological Symptoms of Dementia (BPSD), Behavioural Alternatives to Antipsychotic Drugs, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Call to Action on Antipsychotic Drugs (Dementia Action Alliance), CPPE, Dementia Action Alliance, Dementia Action Alliance (DAA), East & South East England Specialist Pharmacy Services, East of England, Health and Social Care Information Centre, Inappropriate Use of Antipsychotics in Dementia, London, London Antipsychotics Audit and Reduction Exercise in Primary Care, Management of Medicines, Medicines and Falls in Hospital, Medicines for Elderly Linked to Dementia, Medicines Management, Medicines Use and Safety Secondary Care Workshop, National Audit of Dementia Care in Hospitals, National Dementia and Antipsychotic Prescribing Audit 2012, National Prescribing Centre, National Prescribing Service: Australia, NHS London, NHS London: Medicines Use and Safety Team, NHS Sussex, Pharmacists, Prescribing of Antipsychotic Drugs For People With Dementia, Professor Sube Banerjee, Psychological Symptoms of Dementia (BPSD), Reducing Inappropriate Use of Antipsychotics in Dementia, Right Prescription (Dementia Action Alliance), Royal Pharmaceutical Society, Safeguarding and Medicines, South Central & South East Coast, Southampton City NHS Trust, Sussex Partnership NHS Trust, UKMi, Underlying Causes of BPSD
|
Leave a comment
Systematic Review of Treatments to Prevent Cognitive Decline (CMAJ: Journal of the Canadian Medical Association)
Posted on April 27, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary This systematic review examined the best 32 randomised controlled trials (RCTs) investigating treatments for cognitive decline, including drug treatments, hormone therapies, nutritional supplements, physical activity and cognitive exercises. The authors looked comprehensively at pharmacological treatments and non-pharmacological treatments in healthy … Continue reading →
Posted in For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), In the News, International, NHS Choices, Non-Pharmacological Treatments, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Systematic Reviews
|
Tagged Behind the Headlines, Brain Training, Canada, Canadian Medical Association Journal, Cholinesterase Inhibitors, CMAJ: Canadian Medical Association Journal, Cognitive Activity and Cognitive Decline, Cognitive Decline, Cognitive Decline Studies, Cognitive Exercises, Cognitive Impairment, Cognitive Stimulation Therapy, Cognitive Training, Cognitive Training Exercises, DHEA (Synthetic Version of Hormone Produced by Adrenal Glands), Divisions of Geriatric Medicine and General Internal Medicine: University of Toronto, Estrogens, Exercise, Exercise for Cognitive Impairment, Exercise Regimens, Fatty Acids, Fish Oil, Fish-Oil Supplements, Ginkgo Biloba Extract, Hormonal Therapies, Hormone Therapy (HT), Journal de l'Association Medicale Canadienne, MCI, MCI: Mild Cognitive Impairment, Mild Cognitive Impairment, Mild Cognitive Impairment (MCI), Moderate Exercise, NMDA (N-Methyl-D-Aspartate), Nutritional Supplements, Oestrogens, Omega-3 Fatty Acids, Omega-3 PUFA Supplementation (Dietary), Oral Nutritional Supplements, Oral Nutritional Supplements (ONS), Polyunsaturated Fatty Acids (PUFA), Prevention, Prophylaxis, PUFA: Polyunsaturated Fatty Acids, Sudoku, Testosterone, University of Toronto, Vitamin Pills
|
Leave a comment
Alternatives to Antipsychotic Medication (British Psychological Society)
Posted on March 31, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary The Faculty of the Psychology of Older People (FPOP) has released the “Alternatives to Antipsychotic Medication” report in support of the Dementia Action Alliance’s campaign against the over-prescription of antipsychotic medication for people with dementia. This report shows how evidence-based … Continue reading →
Posted in Acute Hospitals, Antipsychotics, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), Management of Condition, Mental Health, Models of Dementia Care, National, Non-Pharmacological Treatments, Patient Care Pathway, Person-Centred Care, Pharmacological Treatments, Practical Advice, Proposed for Next Newsletter, Quick Insights, Standards, UK, Universal Interest
|
Tagged ABC Charts (Antecedent, Agitation, Alternatives to Antipsychotic Medication, Alzheimer's Society, Anti-Psychotic Drugs for Dementia, Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Atypical Antipsychotics, Behavioral and Psychological Symptoms of Dementia (BPSD), Behaviour, Behaviour Monitoring Chart, Behaviour Records (ABC Charts), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, British Psychological Society, British Psychological Society: Division of Clinical Psychology, British Psychological Society: Faculty of the Psychology of Older People (FPOP), Call to Action on Antipsychotic Drugs (Dementia Action Alliance), Challenging Behaviour, Challenging Behaviour Scale (Moniz-Cook 2001), Cognitive Stimulation Therapy (CST), Consequence Charts), Dementia Action Alliance, Dementia Care Mapping, Dementia Care Mapping (Bradford Dementia Group), Dementia Care Mapping (DCM), Dementia with Lewy Bodies, Esk and Wear Valleys NHS Trust, Faculty of Psychology of Older People (PSIGE), Former Health Minister), FPOP: BPS Faculty of the Psychology of Older People, High Intensity Interventions (Protocol-Led Interventions), Leeds & York Partnership NHS Foundation Trust, Low intensity IInterventions (Management of Contextual Issues), Management of Contextual Issues, MHSOP, Music, Northumberland Tyne and Wear NHS Foundation Trust, Occupation (Sense of Purpose), Paul Burstow (Liberal Democrat, Prescribing Anti-Psychotic Drugs to People with Dementia, Professor Sube Banerjee, PSIGE: Faculty for Old Age Psychology (British Psychological Society: Division of Clinical Psychology), Psychological Symptoms of Dementia (BPSD), Psychomotor and Exercise Interventions, Reducing Agitation and Distress, Right Prescription (Dementia Action Alliance), Social Contacts, Specialist Interventions (Individualised Formulation-Led Interventions), Stepped Care Model of Assessment and Intervention, Tees, TREA Model: Treatment Routes for Exploring Agitation (Cohen-Mansfield 2000), Underlying Causes of BPSD, University of Teesside, Wandering, WHELD
|
Leave a comment
Sertraline or Mirtazapine Versus a Placebo for Treatment of Depression in Dementia (HTA-SADD Trial)
Posted on March 10, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary This randomised control trial took place across nine English old-age psychiatry units. It examined the clinical effectiveness of sertraline and mirtazapine in reducing depression compared with a placebo. 326 patients with Alzheimer’s Disease (AD), depression and a Cornell Scale … Continue reading →
Posted in Acute Hospitals, Community Care, Depression, For Doctors (mostly), For Researchers (mostly), Management of Condition, Mental Health, National, NHS, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Systematic Reviews, UK, Universal Interest
|
Tagged Alzheimer's Society, Antidepressants, Antidepressants for Depression in Dementia (HTA-SADD), Behavioral and Psychological Symptoms of Dementia (BPSD), BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, Brighton and Sussex Medical School: University of Sussex, Burden of Dementia, Burden on Caregivers, Caregiving (Carers), Carers, Cornell Scale for Depression in Dementia (CSDD), Dementia Quality of Life (DEMQOL), DEMQOL-Proxy, Department of Community Based Medicine, Department of Mental Health Sciences: University College London, Department of Psychiatry: Liverpool University, Department of Psychiatry: University of Birmingham, Department of Psychiatry: University of Cambridge, Department of Psychiatry: University of Leicester, Department of Psychiatry: University of Southampton, Depression / Dysphoria, Depression in Alzheimer’s Disease Study-II (DIADS)-II, Depression in Dementia, Family Caregivers, Health Services and Population Research Department: King’s College London, Health Technology Assessment Study, HTA-SADD Trial, Hull York Medical School, Institute for Ageing and Health: Newcastle University, Institute of Psychiatry: King's College London, Institute of Rehabilitation: Hull York Medical School, Kings College London, Lancet, Liverpool University, Local Research Ethics Approvals (LREC), Mental Health and Neuroscience Clinical Trials Unit: King’s College London, Mirtazapine, Newcastle University, NIHR Health Technology Assessment Programme, Professor Sube Banerjee, Psychological Symptoms of Dementia (BPSD), Sertraline, Study of Antidepressants for Depression in Dementia (SADD), UK National Institute of Health Research HTA Programme, University College London, University of Birmingham, University of Cambridge, University of East Anglia, University of Leicester, University of Manchester, University of Southampton, University of Sussex, Venlafaxine, Watchful Waiting, Wolfson Centre for Age-Related Disease: King’s College London
|
Leave a comment
Prescription of Psychotropic Drugs in Care Homes (NHS Choices / Journal of the American Geriatrics Society)
Posted on March 4, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary The NHS Choices “Behind the Headlines” service has drawn attention to a further study raising concern over the prescribing of psychotropic medicines for elderly people living in care homes. The study in question examined how psychotropic drugs – i.e. … Continue reading →
Posted in Antipsychotics, BBC News, Community Care, For Carers (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), In the News, International, Management of Condition, NHS Choices, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Standards, Statistics, Universal Interest
|
Tagged Antipsychotic Drugs, Antipsychotics, Antipsychotics and Risk of Venous Thromboembolism, Antipsychotics in Elderly People with Dementia, Anxiolytics, Atypical Antipsychotics, BBC Health News, Behind the Headlines, Belfast, Care Homes, Care Transitions, Care Transitions of Older People, Centre for Public Health: Queen's University Belfast, Checking Medication, Dementia Care in Care Homes, Human Rights in Care Homes, Hypnotics, Institute of Clinical Sciences: Queen's University Belfast, Journal of the American Geriatrics Society, Managing Transitions, Medication, National Data Linkage Study, Northern Ireland, Pharmacoepidemiology, Prescribing of Antipsychotic Drugs For People With Dementia, Psychotropic Drugs, Queen's University Belfast, Reducing Antipsychotic Medication in Care Homes, Residential Care Homes, Sedatives
|
Leave a comment
Inappropriate Long-Term Use of Antipsychotic Drugs for People with Dementia in Specialised Care Units (BMC Pharmacology and Toxicology)
Posted on February 12, 2013 by Dementia and Elderly Care News (an online adjunct to Dementia and Elderly Care: the Latest Evidence)
Summary This study investigated use of antipsychotic drug therapy for the treatment of behavioural and psychological symptoms of dementia (BPSD) among 344 people with dementia living in 40 specialised care units in Sweden. 132 persons (38%) in the study population … Continue reading →
Posted in Antipsychotics, For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), For Social Workers (mostly), International, Mental Health, Pharmacological Treatments, Quick Insights, Universal Interest
|
Tagged Aggression, Aggressive Behaviour, Behavioral and Psychological Symptoms of Dementia (BPSD), BMC Pharmacology and Toxicology, BPSD, BPSD: Behavioral and Psychological Symptoms of Dementia, County Council of Västerbotten, Indications for Antipsychotic Treatment, Lions Research Foundation for Age-Related Diseases, Long-Term Treatment, MCI, Mental Health Care, Mild Cognitive Impairment (MCI), Multi-Dimensional Dementia Assessment Scale (MDDAS), Passive Behaviour, Passivity, Prescribing Patterns, Psychological Symptoms of Dementia (BPSD), Specialised Care Units, Sweden, Swedish Dementia Association, Umeå University (Sweden)
|
Leave a comment
